{"cord_uid": "leaj1t3k", "sourcedb": "PMC", "sourceid": "PMC4033964", "divid": "27", "text": "To date , only few in vi vo studies have been reported with CPP - PNA conjugates [ 98 ] . In the field of antivirals , Pandey and colleagues have started preliminary toxicity , immunological and pharmacokinetic studies in mice for the anti - HIV - 1 PNA TAR - penetratin conjugate [ 99 ] [ 100 ] [ 101 ] . Chaubey et a l . reported the non - toxicity of the complex when administered at repeat doses ranging up to 100 mg / kg [ 99 ] . Mice which were given 100 mg / kg of the conjugate , a dose the authors highlight is far in excess of the expected therapeutic dose , suffered from diarrhea and reduced physical activity and from spleen , liver and kidney serotosis . However they recovered during the 60 - day follow - up period with no irreversible organ damage reported .", "project": "cdlai_CORD-19", "denotations": [{"id": "A-biobert_T1", "span": {"begin": 583, "end": 592}, "obj": "Disease"}, {"id": "A-biobert_T2", "span": {"begin": 631, "end": 667}, "obj": "Disease"}, {"id": "A-biobert_T3", "span": {"begin": 752, "end": 758}, "obj": "Disease"}]}